Zentek Ltd. engages in the research, development, and commercialization of graphene-based novel products. The company is headquartered in Guelph, Ontario and currently employs 17 full-time employees. The company went IPO on 2010-12-22. The firm is focused primarily on commercializing ZenGUARD, as well as on the development of certain aptamer technologies and other nanomaterials-based technologies. ZenGUARD is the Company’s patented anti-microbial coating technology platform. Its platform, ZenGUARD, has been shown to have enhanced bacterial and viral filtration efficiency for surgical masks and heating, ventilation, and air conditioning (HVAC) systems. The firm is also focused on the research, development and commercialization of novel products, seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener. The firm has installed industrial-scale production equipment to produce the ZenGUARD coating formulation. The firm is also working on developing processes to synthesize graphene, GO and graphene quantum dots, along with other possible applications for graphene-based materials.

Industry: Miscellaneous Chemical Products Peers: Bausch + Lomb Corp